SANGAMO THERAPEUTICS, INC.
SGMO · NASDAQ
Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients' lives using gene therapy, cell therapy, and genome engineering.
Market Data
Price
$0.14
+0.02 (+13.26%)
Market Cap$49M
P/E Ratio—
EPS$—
52W High$0.79
52W Low$0.12
Beta1.06
Data from Finnhub · Updated May 1, 2026